- Home
- HKIT vs FBIO Comparison
HKIT vs FBIO Comparison
Compare HKIT & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HKIT | FBIO |
|---|---|---|
| Founded | 1996 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.2M | 113.9M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | HKIT | FBIO |
|---|---|---|
| Price | $1.85 | $3.46 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.50 |
| AVG Volume (30 Days) | 110.7K | ★ 1.2M |
| Earning Date | 10-22-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $1,812,901.00 | ★ $62,303,000.00 |
| Revenue This Year | N/A | $29.71 |
| Revenue Next Year | N/A | $49.34 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.15 | $1.33 |
| 52 Week High | $4.18 | $4.53 |
Technical Indicators
Market Signals| Indicator | HKIT | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 47.19 | 47.17 |
| Support Level | $1.40 | $3.25 |
| Resistance Level | $2.25 | $3.79 |
| Average True Range (ATR) | 0.19 | 0.33 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 60.44 | 18.75 |
Price Performance
Historical ComparisonAbout HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.